Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Dec 10, 2013
Premier Diagnostic Labs ARUP Laboratories, LabCorp, and Quest Diagnostics to Offer the Prosigna Breast Cancer Assay Conference Call to Discuss Details; Tomorrow at 8:30AM EST SEATTLE & SAN ANTONIO--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of l...
Nov 20, 2013
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of David W. Ghesquiere as Senior Vice President, Corporate & Business Development, effective immediately. ...
Nov 18, 2013
SEATTLE, Nov. 18, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG) today announced that its management is scheduled to participate in the Piper Jaffray 25th Annual Healthcare Conference on December 3, 2013 in New York. NanoString management is scheduled to present at 4:30 pm ET. Interested parties can access the live aud...
Nov 12, 2013
Multi-Mode System Available for Running the Prosigna Breast Cancer Assay,Other Multiplexed Research Assays, and Laboratory Developed Tests SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ: NSTG) a provider of life science tools for translational research and molecul...
Nov 5, 2013
- Strong Q3 2013 Revenue Growth of 39% - - Record Instrument Revenue of $3.6 Million, Up 63% - SEATTLE, Nov. 5, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the three and nine ...
Oct 29, 2013
SEATTLE, Oct. 29, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), announced today that its management is scheduled to present at the Credit Suisse 2013 Healthcare Conference in Phoenix on Tuesday, November 12, 2013 at 8:30 am MT/ 10:30 am ET. Interested parties can access the live audio webcast for the conference at ww...
Oct 16, 2013
SEATTLE, Oct. 16, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release 2013 third quarter financial results after the close of trading on Tuesday, November 5, 2013. Company management will hos...
Oct 1, 2013
SEATTLE, Oct. 1, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG) and Fluidigm Corporation (Nasdaq:FLDM) have agreed to settle lawsuits filed by Fluidigm in the United States and Singapore. In the U.S. case, Fluidigm charged NanoString with false advertising, unfair competition, and unlawful trade practices based on a comparison...
Sep 16, 2013
Authors concluded that PAM50 Gene Signature was better than Oncotype DX® and IHC4 Assays at Categorizing Patients into Low and High Risk for Late Distant Recurrence SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ: NSTG) a provider of life science ...
Sep 9, 2013
Prosigna Assay on the nCounter® Dx Analysis System Provides Compelling Clinical Data,Clear Patient Report, and Decentralized Testing in Qualified Labs SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for tr...
Sep 5, 2013
SEATTLE and SAN JOSE, Calif., Sept. 5, 2013 /PRNewswire/ -- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, and BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a colla...
Aug 26, 2013
SEATTLE, Aug. 26, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), today announced that it will be participating in two upcoming investor conferences. NanoString Technologies management is scheduled to participate in the 2013 Morgan Stanley Global Healthcare Conference in New York on Monday, September 9, 2013 at 11:45 a...
Aug 6, 2013
SEATTLE, Aug. 6, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the three and six months ended June 30, 2013. Highlights of the second quarter include: Total revenue of $7.2...
Jul 29, 2013
nCounter Elements General Purpose Reagents are First NanoString Product with Open Architecture to Support Independent Development of Diagnostic Tests SEATTLE & HOUSTON--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational...
Jul 17, 2013
SEATTLE, July 17, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release 2013 second quarter financial results after the close of trading on Tuesday, August 6, 2013. Company management will host...
= add release to Briefcase